(153 days)
No
The description focuses on standard VNG protocols and algorithms for analyzing eye movements, with no mention of AI or ML techniques. The performance studies compare the device to predicate devices using traditional methods, not AI/ML specific metrics.
No.
The device provides information for diagnosis and documentation of vestibular disorders; it does not explicitly state that it treats or alleviates a condition.
Yes
The device provides information to assist in the "diagnosis" of vestibular disorders. It measures, records, displays, and stores images of eye movements, which are then used by a trained medical professional to diagnose these disorders.
Yes
The device description explicitly states that VisualEyes 515/ 525 is a "software program" and that the "goggle hardware is not part of this submission". It is intended to work with existing, previously cleared hardware.
Based on the provided information, the VisualEyes 515/ VisualEyes 525 system is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The system provides information to "assist in the nystagmographic evaluation, diagnosis and documentation of vestibular disorders." This clearly indicates a diagnostic purpose.
- Sample Type: While not explicitly stated as a "sample," the system analyzes eye movements recorded from a camera. Eye movements, in this context, are a physiological signal being measured and analyzed to provide diagnostic information. This aligns with the concept of an in vitro diagnostic device analyzing a biological sample or signal to provide information about a patient's health.
- Analysis Performed: The software "analyzes eye movements," "measures, records, displays and stores" images of eye movements, and performs "standard vestibular tests" to detect and analyze nystagmus. This analysis is performed in vitro (outside the body) on the recorded data.
- Diagnostic Information: The output of the system is used by a trained medical professional to "assist in diagnosing vestibular disorders." This directly links the device's function to providing diagnostic information.
While the device doesn't analyze traditional biological fluids like blood or urine, the analysis of physiological signals like eye movements for diagnostic purposes falls under the scope of IVDs, particularly in the context of providing objective data to aid in the diagnosis of a medical condition. The fact that it's replacing existing cleared IVD devices (K964646 and K072254) further supports this classification.
N/A
Intended Use / Indications for Use
The VisualEyes 515/ VisualEyes 525 system provides information to assist in the nystagmographic evaluation, diagnosis and documentation of vestibular disorders. Nystagmus of the eye is recorded by use of a goggle mounted with cameras. These images are measured, recorded, displayed and stored in the software. This information then can be used by a trained medical professional to assist in diagnosing vestibular disorders. The target population for VisualEyes 515/525 system is 5 years of age+
Product codes
GWN
Device Description
VisualEyes 515/ 525 is a software program that analyzes eye movements recorded from a camera mounted to a video goggle. A standard Video Nystagmography (VNG) protocol is used for the testing. VisualEyes 515/ 525 is replacing the existing Micromedical Technologies Spectrum vestibular testing software system and Interacoustics VN415 and VO425 vestibular testing software (510(k) cleared under K964646 and K072254). The software system will work with the existing Micromedical VisualEyes Goggle and Interacoustics VN415/VO425 Goggle. The goggle hardware is not part of this submission and is still assumed covered by K964646 and K072254. The software is intended to run on a Microsoft Windows PC platform. The "525″ system is a full featured system (all vestibular tests as listed below) while the "515" system has a limited number of tests (indicated with a * below).
VNG in general is used to record nystagmus during oculomotor tests such as saccades, pursuit and gaze testing, optokinetics and also calorics.The VisualEyes 515/ 525 software performs the following standard vestibular tests: *Spontaneous Nystagmus, Gaze, Smooth Pursuit, Saccade, Optokinetic, *Positionals, *Dix-Hallpikes and *Caloric tests. These are exactly the same standard tests that are performed in the predicate devices and are described in the ANSI standard (ANSI S3.45-1999, "American National Standard Procedures for Testing Basic Vestibular Function"). There are no difference in any settings or parameters in these default tests in any of the devices. The clinical validation tests showed that each test was performed in exactly the same manner and resulted in similar findings when comparing VE525 to the predicate devices.
The system consists of a head mounted goggle/mask, a camera unit and a software application running on a standard PC.
Mentions image processing
These images are measured, recorded, displayed and stored in the software.
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Video images from goggle-mounted cameras
Anatomical Site
Eye (for nystagmographic evaluation)
Indicated Patient Age Range
5 years of age+
Intended User / Care Setting
The VisualEyes VNG system is to be used by trained personnel only, such as audiologists, ENT surgeons, doctor's, hearing healthcare professionals or personnel with a similar level of qualifications. The device should not be used without the necessary knowledge and training to understand its use and how results should be interpreted.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The demonstration was carried out as a side by side comparison where the same patient was analysed by the subject device and the predicate device simultaneously. All tests were performed on test subjects with conjugate eye movements. This means that an eye movement on one eye will match the movement of the other eye. One camera recorded the left eye and was processed in the predicate device and the other recorded the right eye and was processed in subject device. All results showed equivalence between the predicates and the subject, this means that results processed in predicates are showing equivalence to results from the subject device.
We have performed clinical comparisons between the three systems. We have reviewed the literature for articles about vestibular testing. All these activities, testing and validation show that VisualEyes 515/ 525 perform as specified and is safe and effective.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.1460 Nystagmograph.
(a)
Identification. A nystagmograph is a device used to measure, record, or visually display the involuntary movements (nystagmus) of the eyeball.(b)
Classification. Class II (performance standards).
0
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 29, 2015
Interacoustics A/S Mr. Erik Nielsen Director, Regulatory & Compliance Audiometer Allé 1 5500Middelfart Denmark
Re: K152112
Trade/Device Name: Visualeyes Regulation Number: 21 CFR 882.1460 Regulation Name: Nystagmograph Regulatory Class: Class II Product Code: GWN Dated: November 28, 2015 Received: December 2, 2015
Dear Mr. Nielsen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"
(21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Srinivas Nandkumar -S
for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K152112
Device Name VisualEyes 515 / VisualEyes 525
Indications for Use (Describe)
The VisualEyes 515/ VisualEyes 525 system provides information to assist in the nystagmographic evaluation, diagnosis and documentation of vestibular disorders. Nystagmus of the eye is recorded by use of a goggle mounted with cameras. These images are measured, recorded, displayed and stored in the software. This information then can be used by a tained medical professional to assist in diagnosing vestibular disorders. The target population for VisualEyes 515/525 system is 5 years of age+
Type of Use (Select one or both, as applicable)
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(K) SUMMARY
VisualEyes 515/ 525
Submitter Information:
| Company Name |
|---|
| Address |
Phone Fax e-mail Contact Person Interacoustics A/S Audiometer Allé 5500 Middelfart Denmark +45 6371 3555 +45 6371 3522 erni@dgs.com Erik Nielsen, Director, Regulatory & Compliance, July 21 2015
Date Summary Prepared
Device Identification:
Trade Name
- Common Name Classification Name Product Code Class Panel Device Class
Predicate Device 1:
Predicate Device
Manufacturer 510(k) No. Date Cleared
Predicate Device 2:
Predicate Device Manufacturer 510(k) No. Date Cleared
VisualEyes 515 VisualEyes 525 Vestibular analysis device Nystagmograph, apparatus, vestibular analysis GWN Neurology Class II (According to 21 CFR 882.1460)
VN415M, VN415B, VO425M, V0425B, 2D-VOG GOGGLES, 2D-VOG SYSTEM Interacoustics A/S K072254 02/05/2008
VIDEO EYE TRAKKER Micromedical Technologies Inc. K964646 07/15/1997
4
VisualEyes 515/ 525 is a software program that analyzes eye movements Device Description recorded from a camera mounted to a video goggle. A standard Video Nystagmography (VNG) protocol is used for the testing. VisualEyes 515/ 525 is replacing the existing Micromedical Technologies Spectrum vestibular testing software system and Interacoustics VN415 and VO425 vestibular testing software (510(k) cleared under K964646 and K072254). The software system will work with the existing Micromedical VisualEyes Goggle and Interacoustics VN415/VO425 Goggle. The goggle hardware is not part of this submission and is still assumed covered by K964646 and K072254. The software is intended to run on a Microsoft Windows PC platform. The "525″ system is a full featured system (all vestibular tests as listed below) while the "515" system has a limited number of tests (indicated with a * below).
VNG in general is used to record nystagmus during oculomotor tests such as saccades, pursuit and gaze testing, optokinetics and also calorics.The VisualEyes 515/ 525 software performs the following standard vestibular tests: *Spontaneous Nystagmus, Gaze, Smooth Pursuit, Saccade, Optokinetic, *Positionals, *Dix-Hallpikes and *Caloric tests. These are exactly the same standard tests that are performed in the predicate devices and are described in the ANSI standard (ANSI S3.45-1999, "American National Standard Procedures for Testing Basic Vestibular Function"). There are no difference in any settings or parameters in these default tests in any of the devices. The clinical validation tests showed that each test was performed in exactly the same manner and resulted in similar findings when comparing VE525 to the predicate devices.
| Indications for Use The VisualEyes 515/ VisualEyes 525 system provides information to assist
in the nystagmographic evaluation, diagnosis and documentation of
vestibular disorders. Nystagmus of the eye is recorded by use of a goggle
mounted with cameras. These images are measured, recorded, displayed
and stored in the software. This information then can be used by a trained
medical professional to assist in diagnosing vestibular disorders. The
| target population for VisualEyes 515/525 system is 5 years of age+ |
|---|
- Intended operator The VisualEyes VNG system is to be used by trained personnel only, such as audiologists, ENT surgeons, doctor's, hearing healthcare professionals or personnel with a similar level of qualifications. The device should not be used without the necessary knowledge and training to understand its use and how results should be interpreted.
Technological The system consists of a head mounted goggle/mask, a camera unit and a characteristics software application running on a standard PC.
5
Product Comparisons - Indications for use
We have chosen to compare the VisualEyes 515/ 525 software with VN415M, VN415B, VO425M, V0425B, 2D-VOG GOGGLES, 2D-VOG SYSTEM and VIDEO EYE TRAKKER for the following reasons.
- The product is a joint development between Micromedical Technologies and Interacoustics ● to create a mutual software platform for the companies' eye tracking systems
- VisualEyes 515/ 525 supports the hardware (goggles) from both systems
- . Both predicate systems have previously obtained FDA 510(k) clearance
- Both predicate systems have the same medical purpose so it is easy to compare validation results
| VN415m, VN415b, VO425m,
| VO425b | VisualEyes 515/ 525 | Discussion |
|---|---|---|
| Assist in the Oculographic | ||
| evaluation, diagnosis and | ||
| documentation of vestibular | ||
| disorders. | Assist in the | |
| nystagmographic | ||
| evaluation, diagnosis and | ||
| documentation of vestibular | ||
| disorders | The word nystagmographic is | |
| used instead of Oculographic | ||
| as it is currently a more | ||
| general term in literature | ||
| Recorded by use of goggle | ||
| mounted cameras | Recorded by use of a goggle | |
| mounted with cameras | Same | |
| This information then can be | ||
| used by a trained medical | ||
| professional to assist in | ||
| diagnosing vestibular disorders. | This information then can | |
| be used by a trained | ||
| medical professional to | ||
| assist in diagnosing | ||
| vestibular disorders. | Same intended operator group | |
| No population age limits | Population limit is 5 years of | |
| age +. | The age limitation (5 years of | |
| age +) has been added as the | ||
| system is not designed for | ||
| children under age 5 as the | ||
| goggle does not fit very small | ||
| faces well. We appraise it as | ||
| similar indications as it is a | ||
| practical restriction. |
VN415m, VN415b, VO425m, VO425b vs. VisualEyes 515/ 525
We appraise that the indications for use for these two systems are similar as both systems claim:
VIDEO EYE TRAKKER vs. VisualEyes 515/ 525
| VIDEO EYE TRAKKER | VisualEyes 515 / 525 | Discussion |
|---|---|---|
| Routine electronystagmography | Assist in the | |
| nystagmographic | ||
| evaluation, diagnosis and | ||
| documentation of vestibular | ||
| disorders | The term | |
| "electronystagmography" is not | ||
| relevant in this application as | ||
| video is used but "Routine | ||
| nystagmography" and |
6
| "nystagmographic evaluation" have equivalence indications | ||
|---|---|---|
| Using miniature video cameras | ||
| and pupil tracking hardware | Recorded by use of a goggle | |
| mounted with cameras | Camera method is identical | |
| No population age limits | Population limit is age 5 | |
| years of age +. | The age limitation (5 years of age +) has been added as the system is not designed for children under age 5 as the goggle does not fit very small faces well. We appraise it as similar indications as it is a practical restriction. |
Summary of IFU similarities
We appraise that the slightly different phrasing in the indications for use are the only deviation in the comparisons. The deviations are discussed above and appraised to be substantially equivalent and hence do not raise any issues regarding safety and efficiency
Performance Tests
We presented a comparison of the subject device and the predicate devices to demonstrate that the key algorithms for detecting and analysing nystagmus were similar. The demonstration was carried out as a side by side comparison where the same patient was analysed by the subject device and the predicate device simultaneously. All tests were performed on test subjects with conjugate eye movements. This means that an eye movement on one eye will match the movement of the other eye. One camera recorded the left eye and was processed in the predicate device and the other recorded the right eye and was processed in subject device. All results showed equivalence between the predicates and the subject, this means that results processed in predicates are showing equivalence to results from the subject device.
Clinical tests
We have performed clinical comparisons between the three systems. We have reviewed the literature for articles about vestibular testing. All these activities, testing and validation show that VisualEyes 515/ 525 perform as specified and is safe and effective.
Discussion of differences
We did not find any essential or major differences between the devices.
Conclusion
We have compared key issues for the VisualEyes 515/ 525 and the predicate devices. We have performed a comparison validation between VisualEyes 515/ 525 and the predicate devices. All similarities and differences have been discussed. We trust that the results of these comparisons demonstrate that the VisualEyes 515/ 525 is substantially equivalent to the marketed predicate devices.
Any deviations between VisualEyes 515/ 525 and predicate devices are appraised to have no adverse effect on the safety and effectiveness of the device.